Canlyniadau Chwilio - Arndt Vogel

Mireinio'r Canlyniadau
  1. 1
    Autoimmune Hepatitis, From Mechanisms to Therapy

    Autoimmune Hepatitis, From Mechanisms to Therapy gan Michael P. Manns, Arndt Vogel

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Epidemiology and Risk Factors of Cholangiocarcinoma

    Epidemiology and Risk Factors of Cholangiocarcinoma gan Martha M. Kirstein, Arndt Vogel

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next?

    FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next? gan Anna Saborowski, Ulrich Lehmann, Arndt Vogel

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

    Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis gan Arndt Vogel, Christian P. Strassburg, Michael P. Manns

    Cyhoeddwyd 2002
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    FGFR2 Inhibition in Cholangiocarcinoma

    FGFR2 Inhibition in Cholangiocarcinoma gan Arndt Vogel, Oreste Segatto, Albrecht Stenzinger, Anna Saborowski

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies

    Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies gan Arndt Vogel, Ralf‐Dieter Hofheinz, Stefan Kubicka, Dirk Arnold

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    The Diagnosis and Treatment of Cholangiocarcinoma

    The Diagnosis and Treatment of Cholangiocarcinoma gan Arndt Vogel, Henning Wege, Karel Caca, Björn Nashan, Ulf P. Neumann

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice

    Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice gan Ângelo Zambam de Mattos, Isadora Bombassaro, Arndt Vogel, José D. Debes

    Cyhoeddwyd 2024
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab gan Chiun Hsu, Lorenza Rimassa, Hui‐Chuan Sun, Arndt Vogel, Ahmed O. Kaseb

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma

    Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma gan Gajanan Kendre, Karthikeyan Murugesan, Tilman Brummer, Oreste Segatto, Anna Saborowski, Arndt Vogel

    Cyhoeddwyd 2022
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Systemic Therapy of Advanced Hepatocellular Carcinoma

    Systemic Therapy of Advanced Hepatocellular Carcinoma gan Peter R. Galle, Jean‐François Dufour, Markus Peck‐Radosavljevic, Jörg Trojan, Arndt Vogel

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer

    UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer gan Johann Ockenga, Arndt Vogel, Niels Teich, Volker Keim, Michael P. Manns, Christian P. Strassburg

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data

    Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data gan Martha M. Kirstein, Ansgar Lange, Anne Prenzler, Michael P. Manns, Stefan Kubicka, Arndt Vogel

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing

    Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing gan Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, Ángela Lamarca, Paul Hofman, Luigi Terracciano, Nicola Normanno

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4

    Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4 gan Ursula Ehmer, Arndt Vogel, Jan Karl Schütte, B Krone, Michael P. Manns, Christian P. Strassburg

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Next-Generation Biomarkers for Cholangiocarcinoma

    Next-Generation Biomarkers for Cholangiocarcinoma gan Pedro M. Rodrigues, Arndt Vogel, Marco Arrese, Domingo Balderramo, Juan W. Valle, Jesús M. Bañales

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy

    Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy gan Ângelo Zambam de Mattos, José D. Debes, André Boonstra, Arndt Vogel, Ângelo Alves de Mattos

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up gan Florian Lordick, Fátima Carneiro, Stefano Cascinu, Tania Fleitas, Karin Haustermans, Guillaume Piessen, Arndt Vogel, Elizabeth Smyth

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

    Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines gan Arndt Vogel, Erika Martinelli, Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer

    A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer gan Ansgar Lange, Anne Prenzler, Martin Frank, Martha M. Kirstein, Arndt Vogel, Johann‐Matthias Graf von der Schulenburg

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: